Skip to content

Grappler® Interference Screw Post-Market Clinical Follow-Up Study

Grappler® Interference Screw Post-Market Clinical Follow-Up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04893824
Enrollment
50
Registered
2021-05-20
Start date
2021-04-19
Completion date
2022-03-25
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendon Rupture, Ankle Injuries, Ankle Inversion Sprain, Ankle Sprains, Deltoid Ankle Sprain, Flexor Digitorum Longus on the Left, Flexor Digitorum Longus on the Right, Flexor Hallucis Longus on the Left, Flexor Hallucis Longus on the Right, Syndesmotic Injuries

Brief summary

Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.

Detailed description

This is a ambispective, multi-surgeon, single site, consecutive case series. Data collection will occur in two phases. Retrospective data collection will occur upon subject identification, and data will be collected from the site's medical records for minimum of 50 subjects who have undergone soft tissue to bone fixation with the Grappler® Interference Screw System. Data will be collected from the subjects' pre-op visits, intra-op visits, 7 week post-op follow-up visits (± 4 weeks), and 6 month post-op follow-up visits (± 4 weeks). The subject must have adequate radiographic and medical records for the minimum follow up requirement of 6 months. Prospective data collection will occur upon subject's provision of written informed consent, and data will be collected from patient reported outcomes (PRO's).

Interventions

DEVICEGrappler® Interference Screw System

Foot and/or ankle procedure involving soft tissue attachment to bone using the Grappler® Interference Screw System

Sponsors

Paragon 28
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL

Inclusion criteria

* The subject must have undergone a foot and/or ankle procedure involving soft tissue attachment to bone using the Grappler® Interference Screw System and completed by one of the designated investigators who are experienced in the use of such implants and the required specialized surgical techniques * The subject must have adequate radiographic and medical records for the minimum follow-up requirement of six months For the Prospective Data Collection: \- The subject is willing to provide written informed consent

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Incidence of revisions6 Months Post-OpSafety will be assessed by recording the incidence of revisions. The relationship of events will be attributed to either the implant or instrumentation.
Incidence of adverse events6 Months Post-OpSafety will be assessed by recording the incidence of adverse events. The relationship of events will be attributed to either the implant or instrumentation.
Incidence of complications6 Months Post-OpSafety will be assessed by recording the incidence of complications. The relationship of events will be attributed to either the implant or instrumentation.

Secondary

MeasureTime frameDescription
Rate of screw removal7 Weeks Post-Op, 6 Months Post-OpSafety as related to rate of screw removal
Foot and Ankle Mobility Measure6 months post-operativeDevice performance and benefits as related to Foot and Ankle Mobility Measure Activities of Daily Living (0-84) and sports (0-32) subscales. The higher the score, the higher the level of function, with 100% representing no dysfunction.
Rate of recurrence of deformity7 Weeks Post-Op, 6 Months Post-OpSafety as related to rate of recurrence of deformity
Patient satisfaction6 months post-operativeDevice performance and benefits as related to patient satisfaction (very satisfied, good, fair, not satisfied)
Visual Analog Scale6 months post-operativeDevice performance and benefits as related to pain levels based on the Visual Analog Scale (range: 0 to 100; 0 = no pain; 100 = worst pain imaginable)
Rate of implant failureIntra-Op, 7 Weeks Post-Op, 6 Months Post-OpSafety as related to rate of implant failure
Rate of re-tear or re-rupture of fixated soft tissue7 Weeks Post-Op, 6 Months Post-OpSafety as related to rate of re-tear or re-rupture of fixated soft tissue

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026